Data WHO/UNICEF & CDC · 21 October 2026 How grades work · Changelog · Corrections

Open Source Medicine Foundation

Naoero

Coverage to 2025 · cases to 2025

Vaccination rates and reported vaccine-preventable disease in Naoero, with a data-quality grade on every series.

← All countries · Western Pacific

71%
MCV1
2025 · WHO/UNICEF estimate
66%
DTP3
2025 · WHO/UNICEF estimate
66%
HepB3
2025 · WHO/UNICEF estimate
0
Measles cases
2024 reported
0
Pertussis (whooping cough) cases
2019 reported

Two kinds of number live on this page. Coverage is the share of the target cohort vaccinated, as estimated by WHO and UNICEF each July from the country's reports, surveys and other evidence, shown beside what the country itself reported. Reported cases are what the national surveillance system sent to WHO; they are a floor, not a count of infections. Every row carries a grade; hover or focus it for the reason, or read how grades are assigned.

Vaccination coverage

Vaccination coverage by antigen, latest WHO/UNICEF estimate, country-reported figure, trend since 2000 and data-quality grade
VaccineLatest estimateCountry-reportedTrend since 2000Data quality
BCGTuberculosis vaccine at birth99%2025 · WHO/UNICEF estimate100%BCG coverage: 2000 to 2025, latest 99% in 2025, lowest 90%, highest 99%.A · strong
DTP1First dose of diphtheria-tetanus-pertussis95%2025 · WHO/UNICEF estimate94.6%DTP1 coverage: 2000 to 2025, latest 95% in 2025, lowest 85%, highest 99%.B · good
DTP3Third dose of diphtheria-tetanus-pertussis (the WHO benchmark of a working programme)66%2025 · WHO/UNICEF estimate65.8%DTP3 coverage: 2000 to 2025, latest 66% in 2025, lowest 44%, highest 99%.B · good
IPV1First dose of inactivated polio vaccine66%2025 · WHO/UNICEF estimate66.1%IPV1 coverage: 2015 to 2025, latest 66% in 2025, lowest 66%, highest 99%.A · strong
IPV completeInactivated polio vaccine, complete primary series—% · Administrative (country-reported)—too few pointsno data
MCV1First dose of measles-containing vaccine71%2025 · WHO/UNICEF estimate70.9%MCV1 coverage: 2000 to 2025, latest 71% in 2025, lowest 8%, highest 99%.B · good
MCV2Second dose of measles-containing vaccine51%2025 · WHO/UNICEF estimate51.4%MCV2 coverage: 2001 to 2025, latest 51% in 2025, lowest 50%, highest 99%.B · good
RCV1First dose of rubella-containing vaccine71%2025 · WHO/UNICEF estimate70.9%RCV1 coverage: 2006 to 2025, latest 71% in 2025, lowest 71%, highest 99%.B · good
HepB3Third dose of hepatitis B vaccine66%2025 · WHO/UNICEF estimate—HepB3 coverage: 2000 to 2025, latest 66% in 2025, lowest 58%, highest 99%.A · strong
HepB birthHepatitis B birth dose within 24 hours99%2025 · WHO/UNICEF estimate100%HepB birth coverage: 2000 to 2025, latest 99% in 2025, lowest 90%, highest 99%.A · strong
Hib3Third dose of Haemophilus influenzae type b vaccine66%2025 · WHO/UNICEF estimate—Hib3 coverage: 2009 to 2025, latest 66% in 2025, lowest 66%, highest 99%.A · strong
PCV1Pneumococcal conjugate vaccine, first dose93.3%2025 · Administrative (country-reported)93.3%PCV1 coverage: 2021 to 2025, latest 93.35% in 2025, lowest 62.72%, highest 100.3%.D · poor
PCV completePneumococcal conjugate vaccine, final dose of the schedule66%2025 · WHO/UNICEF estimate65.5%PCV complete coverage: 2021 to 2025, latest 66% in 2025, lowest 59%, highest 97%.C · weak
RotaCRotavirus vaccine, complete series65%2025 · WHO/UNICEF estimate65.2%RotaC coverage: 2021 to 2025, latest 65% in 2025, lowest 60%, highest 97%.C · weak
Yellow feverYellow fever vaccine (countries at risk)—% · Administrative (country-reported)—too few pointsno data
MenAMeningococcal A conjugate (meningitis belt)—% · Administrative (country-reported)—too few pointsno data
JEJapanese encephalitis vaccine (countries at risk)—% · Administrative (country-reported)—too few pointsno data
TCVTyphoid conjugate vaccine—% · Administrative (country-reported)—too few pointsno data
PABProtection at birth against neonatal tetanus (maternal tetanus doses)100%2025 · Administrative (country-reported)100%too few pointsD · poor
HPV dose 1, girlsHPV programme coverage, first dose, girls14%2025 · WHO/UNICEF estimate—HPV dose 1, girls coverage: 2024 to 2025, latest 14% in 2025, lowest 13%, highest 14%.D · poor
HPV complete, girlsHPV programme coverage, complete series, girls6%2025 · WHO/UNICEF estimate—HPV complete, girls coverage: 2024 to 2025, latest 6% in 2025, lowest 6%, highest 6%.D · poor
HPV dose 1, boysHPV programme coverage, first dose, boys—% · Administrative (country-reported)—too few pointsno data

Reported vaccine-preventable disease

Reported cases and incidence by disease, latest year, trend since 2000 and data-quality grade
DiseaseReported casesIncidence rateTrend since 2000Data quality
Measles all countries · vaccine evidence020240per 1,000,000 total populationMeasles reported cases: 2000 to 2024, latest 0 in 2024, lowest 0, highest 11.D · poor
Rubella all countries · vaccine evidence020240per 1,000,000 total populationRubella reported cases: 2000 to 2024, latest 0 in 2024, lowest 0, highest 0.D · poor
Congenital rubella syndrome all countries · vaccine evidence020190per 10,000 live birthsCongenital rubella syndrome reported cases: 2000 to 2019, latest 0 in 2019, lowest 0, highest 0.D · poor
Mumps all countries · vaccine evidence020110per 1,000,000 total populationMumps reported cases: 2000 to 2011, latest 0 in 2011, lowest 0, highest 0.no data
Pertussis (whooping cough) all countries · vaccine evidence020190per 1,000,000 total populationPertussis (whooping cough) reported cases: 2000 to 2019, latest 0 in 2019, lowest 0, highest 0.D · poor
Diphtheria all countries · vaccine evidence020190per 1,000,000 total populationDiphtheria reported cases: 2000 to 2019, latest 0 in 2019, lowest 0, highest 0.D · poor
Tetanus (total) all countries · vaccine evidence020190per 1,000,000 total populationTetanus (total) reported cases: 2000 to 2019, latest 0 in 2019, lowest 0, highest 1.D · poor
Neonatal tetanus all countries · vaccine evidence020190per 1,000 live birthsNeonatal tetanus reported cases: 2000 to 2019, latest 0 in 2019, lowest 0, highest 0.D · poor
Polio (paralytic) all countries · vaccine evidence020100per 1,000,000 <15 populationPolio (paralytic) reported cases: 2000 to 2010, latest 0 in 2010, lowest 0, highest 0.no data
Yellow fever all countries · vaccine evidence020190per 1,000,000 total populationYellow fever reported cases: 2001 to 2019, latest 0 in 2019, lowest 0, highest 0.D · poor
Japanese encephalitis all countries · vaccine evidence020190per 1,000,000 total populationJapanese encephalitis reported cases: 2006 to 2019, latest 0 in 2019, lowest 0, highest 0.D · poor
Typhoid all countries · vaccine evidence020190per 1,000,000 total populationtoo few pointsD · poor

National schedule (latest WHO listing)

Show the schedule (31 rows)
National immunization schedule
VaccineDoseAgeTarget groupComment
BCGBCG (Baccille Calmette Guérin) vaccine1BGeneral/routine
DTAPDTaP (acellular) vaccine4M18General/routine
DTAPDTaP (acellular) vaccine5Y4General/routine
DTWPHIBHEPBDTwP-Hib-HepB (Whole cell) vaccine1W6General/routine
DTWPHIBHEPBDTwP-Hib-HepB (Whole cell) vaccine2W10General/routine
DTWPHIBHEPBDTwP-Hib-HepB (Whole cell) vaccine3W14General/routine
HEPB_ADULTAdult Hepatitis B (HepB) vaccine11st contactHealth workers
HEPB_ADULTAdult Hepatitis B (HepB) vaccine2+M1Health workers
HEPB_ADULTAdult Hepatitis B (HepB) vaccine3+M2Health workers
HEPB_PEDIATRICPediatric Hepatitis B (HepB) vaccine1BGeneral/routine
HPV2HPV-2 (Human papillomavirus 2-valent) vaccine1Y11-Y14HPV for females onlyFemales
HPV2HPV-2 (Human papillomavirus 2-valent) vaccine2Y11-Y14HPV for females onlyFemales
INFLUENZA_ADULTAdult seasonal influenza vaccine1>Y18Adultsand older persons
INFLUENZA_ADULTAdult seasonal influenza vaccine1Health workersHealth and care workers
INFLUENZA_ADULTAdult seasonal influenza vaccine1Pregnant womenPregnant women
INFLUENZA_ADULTAdult seasonal influenza vaccine1Risk group(s)Adults with chronic conditions
INFLUENZA_PEDIATRICPediatric seasonal influenza vaccine1>=M6General/routine
INFLUENZA_PEDIATRICPediatric seasonal influenza vaccine1Risk group(s)Children with chronic conditions
IPVIPV (Inactivated polio vaccine)1W14General/routine
MRMR (Measles and rubella) vaccine1M12General/routine
MRMR (Measles and rubella) vaccine2M15General/routine
OPVOPV (Oral polio vaccine)1W6General/routine
OPVOPV (Oral polio vaccine)2W10General/routine
OPVOPV (Oral polio vaccine)3W14General/routine
PCV13PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine1W6General/routine
PCV13PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine2W10General/routine
PCV13PCV-13 (Pneumococcal conjugate vaccine 13-valent) vaccine3W14General/routine
ROTAVIRUS_1RV-1 (Rotavirus 1-valent) vaccine1W6General/routine
ROTAVIRUS_1RV-1 (Rotavirus 1-valent) vaccine2W14General/routine
TD_STd (Tetanus toxoid and diphtheria for older children and adults) vaccine11st contactPregnant womenPregnant women: 1st dose in 1st trimester and 2nd dose in 2nd trimester
TD_STd (Tetanus toxoid and diphtheria for older children and adults) vaccine2+M1Pregnant womenPregnant women: 1st dose in 1st trimester and 2nd dose in 2nd trimester

Compare schedules across 31 countries on the schedule hub.

Data and sources

Coverage figures are WHO/UNICEF estimates unless a row says otherwise; reported cases are what national authorities sent to WHO and undercount true infections. Each series carries a data-quality grade that says why.

Cite this page. Naoero. Vaccine Data Navigator, Open Source Medicine Foundation. Built 21 October 2026 from WHO/UNICEF (WIISE) exports and CDC SchoolVaxView. https://vaccinedatanavigator.org/disease-risk/countries/nru.html

Report an error